Document Detail


Papillary renal cell carcinoma with cutaneous metastases.
MedLine Citation:
PMID:  20234300     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cutaneous metastasis is a rare form of presentation of renal cell carcinoma (RCC). Case reports and case series of RCC with skin metastasis in the English literature from 1972 to 2008 were identified by searching the keywords "renal cell cancer," "papillary renal cell tumor," "skin metastasis," and "cutaneous metastasis" in the National Library of Medicine, PUBMED, OVID, and EMBASE search engines. Although a few cases of RCC with skin metastasis are reported in the literature, almost all are clear cell histologic type. We are reporting a unique case of papillary RCC with cutaneous metastases diagnosed at our institution along with a comprehensive literature review of papillary RCC etiology, clinical presentation, prognosis, diagnosis, and the treatment options that are currently available.
Authors:
Nandakumar Srinivasan; Aneesh Pakala; Aref Al-Kali; Shradha Rathi; Waqar Ahmad
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The American journal of the medical sciences     Volume:  339     ISSN:  1538-2990     ISO Abbreviation:  Am. J. Med. Sci.     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-05-13     Completed Date:  2010-06-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370506     Medline TA:  Am J Med Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  458-61     Citation Subset:  AIM; IM    
Affiliation:
Department of Internal Medicine, Health Science Center, University of Oklahoma, Oklahoma City, Oklahoma 73190, USA. nandakumar-srinivasan@ouhsc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / therapeutic use
Carcinoma, Renal Cell / drug therapy,  pathology*
Humans
Male
Middle Aged
Sirolimus / analogs & derivatives,  therapeutic use
Skin Neoplasms / drug therapy,  secondary*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/temsirolimus; 53123-88-9/Sirolimus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Exploring the effect of parathyroidectomy for tertiary hyperparathyroidism after kidney transplantat...
Next Document:  Combination Therapy of Calcium Channel Blocker and Angiotensin II Receptor Blocker Reduces Augmentat...